• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道-大脑连接与发作性偏头痛:最新进展。

The Gut-brain Connection and Episodic Migraine: an Update.

机构信息

Stanford University, Palo Alto, CA, USA.

Metrodora Institute, West Valley City, UT, USA.

出版信息

Curr Pain Headache Rep. 2023 Nov;27(11):765-774. doi: 10.1007/s11916-023-01175-6. Epub 2023 Oct 4.

DOI:10.1007/s11916-023-01175-6
PMID:37792173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10713702/
Abstract

PURPOSE OF REVIEW

Historical evidence suggests a shared underlying etiology for migraine and gastrointestinal (GI) disorders that involves the gut-brain axis. Here we provide narrative review of recent literature on the gut-brain connection and migraine to emphasize the importance of tailoring treatment plans for patients with episodic migraine who experience GI comorbidities and symptoms.

RECENT FINDINGS

Recent population-based studies report the prevalence of migraine and GI disorders as comorbidities as well as overlapping symptomology. American Headache Society (AHS) guidelines have integrated GI symptoms as part of migraine diagnostic criteria and recommend nonoral therapies for patients with GI symptoms or conditions. Nasal delivery is a recommended nonoral alternative; however, it is important to understand potential adverse events that may cause or worsen GI symptoms in some patients due to the site of drug deposition within the nasal cavity with some nasal therapies. Lastly, clinical perspectives emphasize the importance of identifying GI symptoms and comorbidities in patients with episodic migraine to best individualize migraine management. Support for an association between the gut-brain axis and migraine continues to prevail in recent literature; however, the relationship remains complex and not well elucidated. The presence of GI comorbidities and symptoms must be carefully considered when making treatment decisions for patients with episodic migraine.

摘要

目的综述

历史证据表明,偏头痛和胃肠道(GI)疾病之间存在共同的潜在病因,涉及肠-脑轴。本文对近年来关于肠-脑联系与偏头痛的文献进行综述,强调为伴有 GI 共病和症状的发作性偏头痛患者制定治疗计划的重要性。

最近的发现

最近的基于人群的研究报告偏头痛和 GI 疾病作为共病以及重叠症状的患病率。美国头痛协会(AHS)指南已将 GI 症状纳入偏头痛诊断标准的一部分,并为有 GI 症状或疾病的患者推荐非口服治疗。鼻腔给药是一种推荐的非口服替代方案;然而,由于某些鼻腔治疗药物在鼻腔内的沉积部位,了解可能导致或加重某些患者 GI 症状的潜在不良反应非常重要。最后,临床观点强调了在发作性偏头痛患者中识别 GI 症状和共病的重要性,以便更好地个体化偏头痛管理。最近的文献继续支持肠-脑轴与偏头痛之间的关联,但这种关系仍然很复杂,尚未得到很好的阐明。在为发作性偏头痛患者做出治疗决策时,必须仔细考虑 GI 共病和症状的存在。

相似文献

1
The Gut-brain Connection and Episodic Migraine: an Update.肠道-大脑连接与发作性偏头痛:最新进展。
Curr Pain Headache Rep. 2023 Nov;27(11):765-774. doi: 10.1007/s11916-023-01175-6. Epub 2023 Oct 4.
2
A link between gastrointestinal disorders and migraine: Insights into the gut-brain connection.胃肠道疾病与偏头痛之间的关联:肠道-大脑连接的新视角。
Headache. 2021 Apr;61(4):576-589. doi: 10.1111/head.14099. Epub 2021 Apr 1.
3
Episodic Migraine and Older Adults.发作性偏头痛与老年人。
Curr Pain Headache Rep. 2022 Apr;26(4):331-335. doi: 10.1007/s11916-022-01029-7. Epub 2022 Apr 6.
4
Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.偏头痛的共病和合并症及相关的头痛疼痛强度和头痛频率增加的风险:美国偏头痛症状和治疗(MAST)研究的结果。
J Headache Pain. 2020 Mar 2;21(1):23. doi: 10.1186/s10194-020-1084-y.
5
Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention.发作性和慢性偏头痛:打破优化治疗与预防的障碍
Headache. 2015 Mar;55 Suppl 2:103-22; quiz 123-6. doi: 10.1111/head.12505_2.
6
Episodic Migraine and Psychiatric Comorbidity: A Narrative Review of the Literature.发作性偏头痛与精神共病:文献回顾的叙述性综述。
Curr Pain Headache Rep. 2023 Sep;27(9):461-469. doi: 10.1007/s11916-023-01123-4. Epub 2023 Jun 29.
7
Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.预测急性偏头痛药物治疗反应不足:来自美国偏头痛患病率和预防(AMPP)研究的结果。
Headache. 2016 Nov;56(10):1635-1648. doi: 10.1111/head.12941. Epub 2016 Oct 12.
8
Impact of Pre-Existing Migraine and Other Co-Morbid or Co-Occurring Conditions on Presentation and Clinical Course Following Deployment-Related Concussion.与部署相关的脑震荡后,预先存在的偏头痛和其他合并症或共病对表现和临床过程的影响。
Headache. 2020 Mar;60(3):526-541. doi: 10.1111/head.13709. Epub 2020 Jan 3.
9
Sleep disturbance and affective comorbidity among episodic migraineurs.发作性偏头痛患者的睡眠障碍和情感共病。
Headache. 2014 Jan;54(1):116-24. doi: 10.1111/head.12168. Epub 2013 Jun 28.
10
Migraine in Assiut Governorate, Egypt: epidemiology, risk factors, comorbid conditions and predictors of change from episodic to chronic migraine.埃及阿斯尤特省的偏头痛:流行病学、危险因素、合并症以及发作性偏头痛转变为慢性偏头痛的预测因素
Neurol Res. 2016 Mar;38(3):232-41. doi: 10.1080/01616412.2015.1114232. Epub 2016 Mar 28.

引用本文的文献

1
Unravelling the gut-brain connection: a systematic review of migraine and the gut microbiome.解析肠道与大脑的联系:偏头痛与肠道微生物群的系统综述
J Headache Pain. 2025 May 21;26(1):125. doi: 10.1186/s10194-025-02039-7.
2
Breath and Beyond: Advances in Nanomedicine for Oral and Intranasal Aerosol Drug Delivery.呼吸与超越:用于口腔和鼻内气雾剂药物递送的纳米医学进展
Pharmaceuticals (Basel). 2024 Dec 23;17(12):1742. doi: 10.3390/ph17121742.

本文引用的文献

1
Prevalence and associated factors of disorders of gut-brain interaction in the United States: Comparison of two nationwide Internet surveys.肠-脑相互作用障碍在美国的流行情况及其相关因素:两项全国性互联网调查的比较。
Neurogastroenterol Motil. 2023 Jun;35(6):e14564. doi: 10.1111/nmo.14564. Epub 2023 Mar 24.
2
Altered gut microbiota in individuals with episodic and chronic migraine.偏头痛患者肠道微生物组的改变。
Sci Rep. 2023 Jan 12;13(1):626. doi: 10.1038/s41598-023-27586-4.
3
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond.
降钙素基因相关肽的生理学、药理学和治疗靶点:偏头痛及其他。
Physiol Rev. 2023 Apr 1;103(2):1565-1644. doi: 10.1152/physrev.00059.2021. Epub 2022 Dec 1.
4
Comorbidities in patients with migraine in Japan: a cross-sectional study using data from National Health and Wellness Survey.日本偏头痛患者的合并症:一项使用全国健康和健康调查数据的横断面研究。
BMJ Open. 2022 Nov 30;12(11):e065787. doi: 10.1136/bmjopen-2022-065787.
5
Autonomic symptoms in migraine: Results of a prospective longitudinal study.偏头痛中的自主神经症状:一项前瞻性纵向研究的结果。
Front Neurol. 2022 Nov 3;13:1036798. doi: 10.3389/fneur.2022.1036798. eCollection 2022.
6
Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative Review.降钙素基因相关肽在偏头痛胃肠道症状中的作用:临床思考:一篇叙述性综述。
Neurology. 2022 Nov 7;99(19):841-853. doi: 10.1212/WNL.0000000000201332.
7
A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene-related peptide ligand (galcanezumab) or receptor (erenumab) antagonist.一项关于降钙素基因相关肽配体(加兰他敏)或受体(依瑞奈umab)拮抗剂治疗前后成人偏头痛患者胃肠动力的 IV 期临床试验。
Headache. 2022 Oct;62(9):1164-1176. doi: 10.1111/head.14390. Epub 2022 Sep 16.
8
Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action.甲磺酸二氢麦角胺经鼻给药治疗偏头痛急性发作:技术在行动。
J Aerosol Med Pulm Drug Deliv. 2022 Dec;35(6):321-332. doi: 10.1089/jamp.2022.0005. Epub 2022 Sep 14.
9
ACG Clinical Guideline: Gastroparesis.ACG 临床指南:胃轻瘫。
Am J Gastroenterol. 2022 Aug 1;117(8):1197-1220. doi: 10.14309/ajg.0000000000001874. Epub 2022 Jun 3.
10
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update.欧洲头痛联合会关于使用靶向降钙素基因相关肽通路的单克隆抗体预防偏头痛的指南-2022 更新版。
J Headache Pain. 2022 Jun 11;23(1):67. doi: 10.1186/s10194-022-01431-x.